RY 161.29 0.8315% SHOP 116.7 1.6108% TD 83.65 0.553% ENB 61.82 1.2613% BN 68.755 0.8729% TRI 248.88 1.754% CNQ 38.22 0.6054% CP 103.1 0.4775% CNR 138.9 -0.0576% BMO 129.44 1.1013% BNS 65.52 0.7845% CSU 4654.3901 1.9582% CM 81.81 1.3755% MFC 40.37 1.0766% ATD 69.68 -0.9805% NGT 76.14 0.2106% TRP 67.93 2.0123% SU 46.68 0.4735% WCN 273.82 0.8397% L 206.99 -1.499%
Last update at 2025-04-15T16:48:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions
Wed 09 Apr 25, 01:00 PMChina Appeals for Calm, Readies Plans to Counter Trump’s Tariffs
Mon 07 Apr 25, 07:21 AMDupont, GE Health, MP Materials, MarketAxess: Trending Tickers
Fri 04 Apr 25, 04:03 PMWhy GE HealthCare Technologies Stock Fell Today
Thu 03 Apr 25, 06:43 PMMedical device stocks, oil futures, Lamb Weston: Market Minute
Thu 03 Apr 25, 05:15 PMMedical device stocks slide on Trump tariff news
Thu 03 Apr 25, 02:29 PMGE HealthCare Technologies (NasdaqGS:GEHC) Partners With Probo Medical Amid 4% Dip
Wed 02 Apr 25, 06:07 PMGE HealthCare (GEHC) Debuts AI-Powered Cardiology Suite at ACC 2025!
Mon 31 Mar 25, 01:57 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | 2512.00M | 2875.00M | 2710.00M | 2091.00M |
| Minority interest | -51.00000M | -46.00000M | -51.00000M | -29.00000M |
| Net income | 1916.00M | 2247.00M | 2058.00M | 1524.00M |
| Selling general administrative | 3631.00M | 3563.00M | 3237.00M | 3591.00M |
| Selling and marketing expenses | - | - | - | - |
| Gross profit | 7179.00M | 7174.00M | 6767.00M | 6548.00M |
| Reconciled depreciation | 633.00M | 625.00M | 630.00M | 659.00M |
| Ebit | 2522.00M | 2795.00M | 2720.00M | 2124.00M |
| Ebitda | 3222.00M | 3540.00M | 3406.00M | 2838.00M |
| Depreciation and amortization | 700.00M | 745.00M | 686.00M | 714.00M |
| Non operating income net other | - | - | - | - |
| Operating income | 2522.00M | 2795.00M | 2720.00M | 2124.00M |
| Other operating expenses | 15819.00M | 14790.00M | 14444.00M | 14509.00M |
| Interest expense | 77.00M | 40.00M | 66.00M | 88.00M |
| Tax provision | 563.00M | 600.00M | 652.00M | 410.00M |
| Interest income | - | 34.00M | 49.00M | 36.00M |
| Net interest income | -77.00000M | -6.00000M | -17.00000M | -52.00000M |
| Extraordinary items | - | - | - | - |
| Non recurring | - | - | - | - |
| Other items | - | - | - | - |
| Income tax expense | 563.00M | 600.00M | 652.00M | 410.00M |
| Total revenue | 18341.00M | 17585.00M | 17164.00M | 16633.00M |
| Total operating expenses | 4657.00M | 4379.00M | 4047.00M | 4424.00M |
| Cost of revenue | 11162.00M | 10411.00M | 10397.00M | 10085.00M |
| Total other income expense net | -10.00000M | 80.00M | -10.00000M | -33.00000M |
| Discontinued operations | 18.00M | 18.00M | 11839.00M | -128.00000M |
| Net income from continuing ops | 1949.00M | 2275.00M | 2058.00M | 1681.00M |
| Net income applicable to common shares | 1916.00M | 2247.00M | 13846.00M | 1524.00M |
| Preferred stock and other adjustments | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 32454.00M | 27539.00M | 26308.00M | 24228.00M | - |
| Intangible assets | 1253.00M | 1520.00M | 1847.00M | 1603.00M | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 61.00M | 417.00M | 88.00M | 98.00M | - |
| Total liab | 25144.00M | 18177.00M | 9632.00M | 9477.00M | - |
| Total stockholder equity | 7133.00M | 9357.00M | 16655.00M | 14727.00M | - |
| Deferred long term liab | - | 82.00M | 77.00M | 71.00M | - |
| Other current liab | 3000.00M | 2336.00M | 2247.00M | 2417.00M | - |
| Common stock | 5.00M | 11235.00M | 17692.00M | 15566.00M | - |
| Capital stock | 5.00M | 0.00000M | 17692.00M | 15566.00M | - |
| Retained earnings | 1326.00M | - | - | - | - |
| Other liab | - | 2240.00M | 2324.00M | 2699.00M | - |
| Good will | 12936.00M | 12813.00M | 12892.00M | 11868.00M | - |
| Other assets | 3302.00M | 2534.00M | 1993.00M | 2315.00M | - |
| Cash | 2494.00M | 1445.00M | 554.00M | 994.00M | - |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 8981.00M | 7191.00M | 6761.00M | 6524.00M | - |
| Current deferred revenue | 1918.00M | 1896.00M | 1864.00M | 1813.00M | - |
| Net debt | 7369.00M | 6804.00M | -117.00000M | -526.00000M | - |
| Short term debt | 1116.00M | 15.00M | 110.00M | 132.00M | - |
| Short long term debt | 1006.00M | 15.00M | 6.00M | 4.00M | - |
| Short long term debt total | 9863.00M | 8249.00M | 437.00M | 468.00M | - |
| Other stockholder equity | 6493.00M | 18801.00M | -1037.00000M | -839.00000M | - |
| Property plant equipment | - | 2314.00M | 2235.00M | 2202.00M | - |
| Total current assets | 9410.00M | 8318.00M | 7000.00M | 5896.00M | - |
| Long term investments | 357.00M | 322.00M | 341.00M | 344.00M | - |
| Net tangible assets | - | -4976.00000M | 1916.00M | 1256.00M | - |
| Short term investments | - | - | - | - | - |
| Net receivables | 4254.00M | 4301.00M | 3791.00M | 2657.00M | - |
| Long term debt | 8436.00M | 8234.00M | 31.00M | 31.00M | - |
| Inventory | 1960.00M | 2155.00M | 1946.00M | 1594.00M | - |
| Accounts payable | 2947.00M | 2944.00M | 2540.00M | 2162.00M | - |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -691.00000M | -1878.00000M | -1037.00000M | -839.00000M | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 1524.00M | 702.00M | 286.00M | 375.00M | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 23044.00M | 19221.00M | 19308.00M | 18332.00M | - |
| Capital lease obligations | 421.00M | 386.00M | 400.00M | 433.00M | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -398.00000M | -1761.00000M | 19986.00M | -325.00000M |
| Change to liabilities | 619.00M | 242.00M | 199.00M | -48.00000M |
| Total cashflows from investing activities | -398.00000M | -1761.00000M | -323.00000M | -325.00000M |
| Net borrowings | 8204.00M | -12.00000M | -16.00000M | -59.00000M |
| Total cash from financing activities | -822.00000M | -263.00000M | -21544.00000M | -1574.00000M |
| Change to operating activities | -81.00000M | 251.00M | 9.00M | 84.00M |
| Net income | 1949.00M | 2275.00M | 2058.00M | 1681.00M |
| Change in cash | 890.00M | -451.00000M | 143.00M | 35.00M |
| Begin period cash flow | 561.00M | 1012.00M | 869.00M | 834.00M |
| End period cash flow | 1451.00M | 561.00M | 1012.00M | 869.00M |
| Total cash from operating activities | 2113.00M | 1607.00M | 1687.00M | 1989.00M |
| Issuance of capital stock | - | - | - | - |
| Depreciation | 633.00M | 625.00M | 630.00M | 659.00M |
| Other cashflows from investing activities | -92.00000M | -47.00000M | -2.00000M | -46.00000M |
| Dividends paid | - | - | - | - |
| Change to inventory | -402.00000M | -435.00000M | 100.00M | -173.00000M |
| Change to account receivables | -231.00000M | -1336.00000M | -221.00000M | -272.00000M |
| Sale purchase of stock | - | - | - | - |
| Other cashflows from financing activities | -819.00000M | -246.00000M | -21524.00000M | -1511.00000M |
| Change to netincome | -341.00000M | 13.00M | -12876.00000M | 215.00M |
| Capital expenditures | 310.00M | 248.00M | 259.00M | 331.00M |
| Change receivables | - | - | - | - |
| Cash flows other operating | - | - | - | - |
| Exchange rate changes | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - |
| Change in working capital | -256.00000M | -1370.00000M | -52.00000M | -387.00000M |
| Stock based compensation | - | - | -931.00000M | 151.00M |
| Other non cash items | -776.00000M | -523.00000M | -670.00000M | -525.00000M |
| Free cash flow | 1803.00M | 1359.00M | 1428.00M | 1658.00M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies Inc. |
-1.34 2.08% | 63.05 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-1.115 0.50% | 222.54 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 9.45 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
0.04 0.69% | 5.85 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
| TEM Tempus AI, Inc. Class A Common Stock |
-1.28 2.97% | 41.85 | - | - | 13.29 | 80.58 | 13.27 |
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
500 West Monroe Street, Chicago, IL, United States, 60661
| Name | Title | Year Born |
|---|---|---|
| Mr. Peter J. Arduini | President, CEO & Director | 1965 |
| Mr. James K. Saccaro | VP & CFO | 1973 |
| Dr. Taha Kass-Hout M.D., M.S. | Chief Science & Technology Officer | 1972 |
| Mr. Frank R. Jimenez Esq. | VP, General Counsel & Corporate Secretary | 1965 |
| Mr. Jan Makela | President & CEO of Imaging | 1969 |
| Mr. George Andrew Newcomb | Controller & Chief Accounting Officer | 1967 |
| Mr. Jahid Khandaker | Chief Information Officer | NA |
| Ms. Carolynne Borders | Chief Investor Relations Officer | NA |
| Ms. Rana Strellis | Chief Corporate Marketing & Communications Officer | NA |
| Mr. Thomas J. Westrick | President & CEO of Patient Care Solutions | 1969 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA
NZ
UK
US
AU
IND
Please wait processing your request...